US Merger & Acquisition SEC Filings — June 29, 2026
This U.S. M&A and takeover digest spans 11 filings, with a heavy concentration of SPAC activity alongside significant corporate transformations and asset acquisitions. The most critical development is Honeywell's completion of its Aerospace Technologies spin-off, a major strategic pivot that creates three independent, focused leaders and is expected to unlock substantial shareholder value through a pure-play structure. The period also saw a landmark transaction in the real assets management sector, where CIM Real Estate Finance Trust acquired CIM Group's business in a deal that values the combined entity's assets at over $30 billion, though existing CMFT shareholders were diluted to a 32.5% stake. Another notable M&A theme is the trend of early-stage biotech de-SPACs, exemplified by Talawar Therapeutics' merger with JATT II Acquisition Corp, which is bolstered by a massive $285 million in proceeds including an oversubscribed $225 million PIPE. On the lower end of the materiality spectrum, several SPACs are merely extending deadlines or completing administrative steps, such as unit separations, reflecting a challenging environment for finding viable targets. Blue Owl's acquisition of a data center facility in Virginia underscores the growing appetite for digital infrastructure assets. A significant risk flag is raised by Acura Pharmaceuticals, whose debt load has ballooned by 361% since 2022, indicating severe financial distress. Overall, the quarter ended with a clear bifurcation: high-conviction, well-capitalized M&A (Honeywell, Talawar/JATT, Blue Owl) versus capital-constrained, deadline-driven SPACs (CSTAF, Alpex).